Author:
Baldo B.A.,McDonnell N.J.
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine
Reference51 articles.
1. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships;Adam;J Med Chem,2002
2. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969;Epemolu;Anesthesiology,2003
3. Effects of sugammadex doses up to 32mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study;de Kam;Clin Drug Investig,2010
4. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study;Peeters;Clin Drug Investig,2010
5. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review;Schaller;Core Evid,2013
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献